Showing results (441-450 of 494) with videos related to
Sort By:
Pageof 50
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapyThomas A Buchholz, Eugene H Huang, Donald Berry, et al.Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.International Journal of Radiation Oncology, Biology, Physics|April 29, 2008
Locoregional treatment outcomes after multimodality management of inflammatory breast cancerIan J Bristol, Wendy A Woodward, Eric A Strom, et al.JAMA Oncology|January 1, 2016
Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic ChemotherapySarah S Mougalian, Mike Hernandez, Xiudong Lei, et al.Cancer|February 24, 2005
Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinomaKaren H Shahar, Thomas A Buchholz, Ebrahim Delpassand, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.Cancers|June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted TherapyShakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.International Immunopharmacology|May 4, 2004
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 familySunil Chada, R Bryan Sutton, Suhendan Ekmekcioglu, et al.International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosisEugene H Huang, Eric A Strom, Vicente Valero, et al.Pageof 50